Scrip Id

NOVELIX

Novelix Pharmaceuticals Limited has made a regulatory disclosure pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, intimating about two preferential allotments of equity shares approved by the Board of Directors in their meeting held on 9th July, 2026.

First Allotment: Warrant Conversion (Promoter Group)

  • Type of Securities: Equity Shares upon conversion of Warrants
  • Total Number Allotted: 33,75,000 Equity Shares of face value ₹10 each
  • Issue Price: ₹20 per share (₹10 face value + ₹10 premium)
  • Total Consideration Received: ₹5,06,25,000 (Five Crores Six Lakhs Twenty-Five Thousand)
  • Allottees (Promoter & Promoter Group):
  • SRINIDHI FINE-CHEMICALS LLP: 21,00,000 shares
  • NARAHARI BELIDE: 4,00,000 shares
  • VUPPARAPALLI CHANDRASEKHAR REDDY: 7,75,000 shares
  • NEHA GATTU: 1,00,000 shares
  • Capital Impact: Paid-up equity capital increased from ₹23,89,50,000 (23,895,000 shares) to ₹27,27,00,000 (27,270,000 shares)
  • Background: Conversion of 33,75,000 warrants out of 1,50,00,000 warrants allotted on 10th January, 2025, following special resolution passed at Extra-Ordinary General Meeting on November 28th, 2024 and BSE in-principle approval received on December 31st, 2024

Second Allotment: Preferential Issue (Non-Promoter)

  • Type of Securities: Equity Shares
  • Total Number Allotted: 12,00,000 Equity Shares of face value ₹10 each
  • Issue Price: ₹57 per share (₹10 face value + ₹47 premium)
  • Total Consideration Received: ₹6,84,00,000 (Six Crore Eighty-Four Lakhs)
  • Allottees (16 Non-Promoter Investors):
  • PALAKURTHI RAKESH: 1,00,000 shares
  • RAHUL INNANI: 1,00,000 shares
  • SUMAN RAJIV BIHANI: 1,00,000 shares
  • VEDANT RAJIV BIHANI: 1,00,000 shares
  • PRAKASH GALDA: 1,00,000 shares
  • K VARSHA: 50,000 shares
  • VIJAYA SURESH NIMBALE: 25,000 shares
  • PRASANTH SOWMITHRY BRUNDAVANAM: 25,000 shares
  • T PRAVEEN KUMAR: 1,40,000 shares
  • ALLADI PRAVEEN: 50,000 shares
  • GANGADHAR KATHURI: 10,000 shares
  • RAJENDER BELIDE: 1,00,000 shares
  • BELIDE VIJAYALAKSHMI: 1,00,000 shares
  • VENKATRAMANA MANUSANI: 50,000 shares
  • MANUSANI JALAJA LAXMI: 50,000 shares
  • Capital Impact: Paid-up equity capital increased from ₹27,27,00,000 (27,270,000 shares) to ₹28,47,00,000 (28,470,000 shares)
  • Background: Approved through special resolution at Extra Ordinary General Meeting held on 1st July, 2026 and BSE in-principle approval received via letter no. LOD/PREF/DNFIP/1488/2026-27 dated 9th July, 2026

Meeting Details

The Board meeting was held at the company's registered office at H No: 3-6-237/610, Flat No: 610, 6th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana-500029. The meeting commenced at 5:00 PM and concluded at 6:48 PM.